» Authors » Steve Horwitz

Steve Horwitz

Explore the profile of Steve Horwitz including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 203
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Goyal A, OLeary D, Dabaja B, Weng W, Zain J, Cutler C, et al.
Transplant Cell Ther . 2024 Sep; 30(11):1047-1060. PMID: 39222792
Mycosis fungoides (MF) and Sézary syndrome (SS) are the most common subtypes of cutaneous T-cell lymphoma (CTCL). While MF generally follows an indolent course, a subset of patients will experience...
2.
Jagadeesh D, Horwitz S, Bartlett N, Kim Y, Jacobsen E, Duvic M, et al.
Oncologist . 2022 Aug; 27(10):864-873. PMID: 35948003
Background: The safety and efficacy of brentuximab vedotin (BV), an antibody-drug conjugate directed to the CD30 antigen, has been assessed in several trials in patients with peripheral T-cell lymphoma (PTCL),...
3.
Cook L, Fuji S, Hermine O, Bazarbachi A, Ramos J, Ratner L, et al.
J Clin Oncol . 2019 Jan; 37(8):677-687. PMID: 30657736
Purpose: Adult T-cell leukemia-lymphoma (ATL) is a distinct mature T-cell malignancy caused by chronic infection with human T-lymphotropic virus type 1 with diverse clinical features and prognosis. ATL remains a...
4.
Kempf W, Pfaltz K, Vermeer M, Cozzio A, Ortiz-Romero P, Bagot M, et al.
Blood . 2011 Aug; 118(15):4024-35. PMID: 21841159
Primary cutaneous CD30(+) lymphoproliferative disorders (CD30(+) LPDs) are the second most common form of cutaneous T-cell lymphomas and include lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma. Despite the anaplastic...